NASDAQ
Karyopharm Therapeutics Inc. (KPTI) has a free cash flow growth of -92.15% as of Friday, May 29, 2026. This represents a 1034.25% decrease compared to its 12-month average of -8.12%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.